Compare ARVN & TTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ARVN | TTI |
|---|---|---|
| Founded | 2015 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 806.0M | 761.0M |
| IPO Year | 2018 | 1990 |
| Metric | ARVN | TTI |
|---|---|---|
| Price | $12.61 | $9.18 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 23 | 4 |
| Target Price | ★ $17.80 | $8.13 |
| AVG Volume (30 Days) | ★ 2.3M | 2.1M |
| Earning Date | 11-05-2025 | 10-28-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 7085.43 |
| EPS | N/A | ★ 0.92 |
| Revenue | $312,300,000.00 | ★ $618,755,000.00 |
| Revenue This Year | $11.06 | $5.57 |
| Revenue Next Year | N/A | $4.58 |
| P/E Ratio | ★ N/A | $9.93 |
| Revenue Growth | ★ 93.86 | 0.17 |
| 52 Week Low | $5.90 | $2.03 |
| 52 Week High | $24.77 | $9.40 |
| Indicator | ARVN | TTI |
|---|---|---|
| Relative Strength Index (RSI) | 57.85 | 67.23 |
| Support Level | $11.66 | $8.15 |
| Resistance Level | $13.56 | $8.93 |
| Average True Range (ATR) | 0.57 | 0.51 |
| MACD | 0.00 | 0.09 |
| Stochastic Oscillator | 61.43 | 88.48 |
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
Tetra Technologies Inc is a diversified oil and gas services company, focused on completion fluids and associated products and services, water management, frac flowback, production well testing, offshore rig cooling, and compression services. It has two reporting segments namely Completion Fluids & Products, and Water & Flowback Services. The Completion Fluids & Products Division manufactures and markets clear brine fluids, additives, and associated products and services. Majority of revenue is from Completion Fluids & Products. The company derives maximum revenue from United states.